Susan Dana Jones
Chief Technology Officer · Tourmaline Bio, Inc.
Individual
- 2025
- Oct 28, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Susan Dana Jones's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Matthew Rabinowitz - $142.28M in NTRA purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Susan Dana Jones?
Susan Dana Jones is a corporate insider, tracked as Chief Technology Officer of Tourmaline Bio, Inc. (TRML). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Susan Dana Jones last file a Form 4?
The only primary Form 4 on record is dated 28 October 2025.
